Paracetamol–An old drug with new mechanisms of action

GW Przybyła, KA Szychowski… - Clinical and Experimental …, 2021 - Wiley Online Library
Paracetamol (acetaminophen) is the most commonly used over‐the‐counter (OTC) drug in
the world. Despite its popularity and use for many years, the safety of its application and its …

The endocannabinoid system as an emerging target of pharmacotherapy

P Pacher, S Bátkai, G Kunos - Pharmacological reviews, 2006 - Elsevier
The recent identification of cannabinoid receptors and their endogenous lipid ligands has
triggered an exponential growth of studies exploring the endocannabinoid system and its …

The endocannabinoid system and pain

J Guindon, AG Hohmann - CNS & Neurological Disorders-Drug …, 2009 - ingentaconnect.com
The therapeutic potential of cannabinoids has been the topic of extensive investigation
following the discovery of cannabinoid receptors and their endogenous ligands …

Targeting the endocannabinoid system: to enhance or reduce?

V Di Marzo - Nature reviews Drug discovery, 2008 - nature.com
Endocannabinoids are lipid chemical mediators that act locally by activating cannabinoid
receptors of type 1 (CB 1) and type 2 (CB 2) receptors. The two most-studied …

[HTML][HTML] Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside

EJ Rahn, AG Hohmann - Neurotherapeutics, 2009 - Elsevier
Neuropathic pain is a debilitating form of chronic pain resulting from nerve injury, disease
states, or toxic insults. Neuropathic pain is often refractory to conventional …

The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration

JC Ashton, M Glass - Current neuropharmacology, 2007 - ingentaconnect.com
Endocannabinoids are released following brain injury and may protect against excitotoxic
damage during the acute stage of injury. Brain injury also activates microglia in a secondary …

[PDF][PDF] Potential analgesic mechanisms of acetaminophen

HS Smith - Pain physician, 2009 - painphysicianjournal.com
Acetaminophen (APAP) continues to be one of the most popular analgesics available in the
United States despite that the mechanisms of antinociception elicited by APAP are not yet …

Endocannabinoid-based therapies

D Piomelli, A Mabou Tagne - Annual Review of Pharmacology …, 2022 - annualreviews.org
The endocannabinoids are lipid-derived messengers that play a diversity of regulatory roles
in mammalian physiology. Dysfunctions in their activity have been implicated in various …

Cannabichromene is a cannabinoid CB2 receptor agonist

M Udoh, M Santiago, S Devenish… - British Journal of …, 2019 - Wiley Online Library
Background and Purpose Cannabichromene (CBC) is one of the most abundant
phytocannabinoids in Cannabis spp. It has modest antinociceptive and anti‐inflammatory …

Enhanced endocannabinoid tone as a potential target of pharmacotherapy

M Toczek, B Malinowska - Life sciences, 2018 - Elsevier
The endocannabinoid system is up-regulated in numerous pathophysiological states such
as inflammatory, neurodegenerative, gastrointestinal, metabolic and cardiovascular …